In 2024, the Braille system will have been around for 200 years. What better way to mark the occasion than with an open source project devoted to making embossing equipment affordable for the visually ...

[Ancient] has a video showing off a fascinating piece of work: a lip-syncing robot whose animated electro-mechanical mouth works like an IBM Selectric typewriter. The mouth rapidly flips between ...

It's safe to say the era of CD and DVD players has fallen by the wayside. Unfortunately, CD/DVD players are a rare sight in ...

Reflect on the time when the fax machine was a ground-breaking innovation, or when the internet emerged, changing the way businesses connected with their customers. Following that, social media, ...

ISB Online’s Leadership with AI Programme equips senior leaders with strategic AI fluency across Generative AI, Agentic AI, and emerging intelligent systems. Through a 20-week, flexible, and immersive ...

Dianna Gunn built her first WordPress website in 2008. Since then, she's poured thousands of hours into understanding how websites and online businesses work. She's shared what she's learned on blogs ...

In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...

The curriculum covers Python programming, data manipulation, exploratory analysis, and regression. The Indian Institute of Technology (IIT) Delhi has opened applications for the second batch of its ...

Takeda has said it intends to move quickly ahead with regulatory filings for oveporexton, its orexin agonist for sleep disorder narcolepsy, after a clean sweep of positive efficacy data in two phase 3 ...

I've been writing and editing stories for almost two decades that help people use technology and productivity techniques to work better, live better, and protect their privacy and personal data. As ...

A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study, in ...